Loading…
Warnings, uncertainty, and clinical practice
Paediatric anaesthetists in the USA and around the world were surprised in December, 2016, when the US Food and Drug Administration (FDA) issued a Drug Safety Communication warning that exposure to anaesthetic and sedative drugs for more than 3 h may cause adverse effects on the developing brain in...
Saved in:
Published in: | The Lancet (British edition) 2017-06, Vol.389 (10085), p.2174-2176 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Paediatric anaesthetists in the USA and around the world were surprised in December, 2016, when the US Food and Drug Administration (FDA) issued a Drug Safety Communication warning that exposure to anaesthetic and sedative drugs for more than 3 h may cause adverse effects on the developing brain in infants younger than 3 years and in the fetus during the third trimester.1,2 The data on which the public warning was based were well known to practitioners and academics, but release of the warning occurred without advance notice, resulting in considerable consternation among clinicians.3 Evidence from animal studies has accumulated in the past two decades that lengthy general anaesthesia or sedation, both with drugs interacting at the N-methyl-D-aspartate receptor and at the γ-aminobutyric-acid (GABA) A receptor, increased neuroapoptosis, altered synaptogenesis, and resulted in abnormal neurodevelopment and performance in many species, including non-human primates. |
---|---|
ISSN: | 0140-6736 1474-547X |
DOI: | 10.1016/S0140-6736(17)31506-4 |